FLIP (CFLAR) Mouse Monoclonal Antibody [Clone ID: OTI2H8]

CAT#: TA804581

CFLAR mouse monoclonal antibody, clone OTI2H8 (formerly 2H8)

Size: 30 ul 100 ul

Formulation: Standard Carrier-Free

Conjugation: Unconjugated Biotin HRP



  View other "OTI2H8" antibodies (4)

Need it in bulk or conjugated?
Get a free quote

参与“2024逐梦开学季·科研添动力”活动,可提供10 µL试用规格

CNY 1,999.00

CNY 2,700.00


货期*
现货

规格
    • 100 ul

Product images

经常一起买 (4)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Recombinant protein of human CASP8 and FADD-like apoptosis regulator (CFLAR), transcript variant 3, 20 µg
    • 20 ug

CNY 2,900.00
CNY 6,650.00


Transient overexpression lysate of CASP8 and FADD-like apoptosis regulator (CFLAR), transcript variant 3
    • 100 ug

CNY 3,080.00


Transient overexpression lysate of CASP8 and FADD-like apoptosis regulator (CFLAR), transcript variant 1
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Clone Name OTI2H8
Applications IHC, WB
Recommend Dilution WB 1:2000, IHC 1:150
Reactivity Human
Host Mouse
Clonality Monoclonal
Immunogen Human recombinant protein fragment corresponding to amino acids 1-272 of human CFLAR (NP_003870) produced in E.coli.
Formulation PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size 55.2 kDa
Gene Name CASP8 and FADD like apoptosis regulator
Synonyms c-FLIP; c-FLIPL; c-FLIPR; c-FLIPS; CASH; CASP8AP1; Casper; CLARP; FLAME; FLAME-1; FLAME1; FLIP
Reference Data
Protein Families Druggable Genome, Protease
Protein Pathways Apoptosis
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...